Atlas Trials

A Parallel Group Study to Compare Sativex® With Placebo in the Treatment of Detrusor Overactivity in Patients With Multiple Sclerosis

Clinical trial NCT00678795 · COMPLETED

Trial details

NCT number
NCT00678795
Sponsor
Jazz Pharmaceuticals
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Detrusor OveractivityMultiple Sclerosis
Start date
2002-08-01
Primary completion
2005-10-01
Enrollment
135

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.